(LONN) Lonza - Performance 4% in 12m
Compare LONN with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
11.94%
#27 in Group
Rel. Strength
52.92%
#3762 in Universe
Total Return 12m
4.01%
#43 in Group
Total Return 5y
30.97%
#29 in Group
P/E 60.7
86th Percentile in Group
P/E Forward 31.7
77th Percentile in Group
PEG 1.15
88th Percentile in Group
FCF Yield -0.34%
87th Percentile in Group
12m Total Return: LONN (4%) vs XBI (-10.2%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
ABBV NYSE AbbVie |
-18.6% | 9.15% | 153% | 75.1 | 14.6 | 0.38 | -49.6% | -19% |
UTHR NASDAQ United Therapeutics |
-11.8% | 21% | 168% | 11.8 | 10.6 | 1.43 | 83.8% | 78.5% |
HLN NYSE Haleon |
-0.87% | 26.7% | 40.5% | 24.7 | 20.3 | 1.8 | 27.1% | - |
AMGN NASDAQ Amgen |
-12.6% | 8.21% | 36.7% | 38.4 | 14.1 | 0.99 | -18.8% | -20% |
LONN SW Lonza |
-3.71% | 4.01% | 31% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
BIM PA Biomerieux |
-1.04% | 14.6% | 7.58% | 31.5 | 25.4 | 1.47 | -58.7% | -25.1% |
NBIX NASDAQ Neurocrine Biosciences |
-9.08% | -23.9% | -0.25% | 29.1 | 20.7 | 0.27 | 61.5% | 31.6% |
KMDA NASDAQ Kamada |
-4.41% | 31.6% | -2.82% | 24.3 | 22.8 | 0.91 | 47.7% | 3.93% |
Performance Comparison: LONN vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for LONN
Total Return (including Dividends) | LONN | XBI | S&P 500 |
---|---|---|---|
1 Month | -3.71% | -13.99% | -6.90% |
3 Months | -2.74% | -13.68% | -11.64% |
12 Months | 4.01% | -10.17% | 6.50% |
5 Years | 30.97% | -19.71% | 101.06% |
Trend Score (consistency of price movement) | LONN | XBI | S&P 500 |
1 Month | -69.8% | -80.4% | -74.5% |
3 Months | -86.3% | -89.8% | -88.2% |
12 Months | 59.2% | -26.1% | 66.1% |
5 Years | -29.1% | -52.8% | 84.3% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #45 | 12.0% | 3.43% |
3 Month | #38 | 12.7% | 10.1% |
12 Month | #44 | 15.8% | -2.35% |
5 Years | #30 | 63.1% | -34.9% |
FAQs
Does LONN Lonza outperforms the market?
Yes,
over the last 12 months LONN made 4.01%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.17%.
Over the last 3 months LONN made -2.74%, while XBI made -13.68%.
Over the last 3 months LONN made -2.74%, while XBI made -13.68%.
Performance Comparison LONN vs Indeces and Sectors
LONN vs. Indices LONN is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 3.02% | 3.19% | 6.75% | -2.49% |
US NASDAQ 100 | QQQ | 3.84% | 4.16% | 7.04% | -0.92% |
US Dow Jones Industrial 30 | DIA | 4.41% | 2.71% | 6.48% | -1.41% |
German DAX 40 | DAX | 0.22% | 4.80% | -10.3% | -14.6% |
Shanghai Shenzhen CSI 300 | CSI 300 | 2.26% | 4.26% | -0.14% | -2.01% |
Hongkong Hang Seng | HSI | -0.82% | 6.95% | 3.30% | -12.9% |
India NIFTY 50 | INDA | -0.07% | -9.41% | 4.29% | 0.74% |
Brasil Bovespa | EWZ | -0.89% | 0.94% | 4.78% | 13.7% |
LONN vs. Sectors LONN is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 3.69% | 3.27% | -2.45% | -10.1% |
Consumer Discretionary | XLY | 4.70% | 1.92% | 3.99% | -4.53% |
Consumer Staples | XLP | 0.19% | -5.74% | -3.34% | -10.5% |
Energy | XLE | -2.50% | 6.22% | 6.34% | 14.6% |
Financial | XLF | 1.76% | 0.92% | -1.04% | -15.4% |
Health Care | XLV | 2.93% | 3.62% | 8.06% | 4.56% |
Industrial | XLI | 1.90% | 1.75% | 6.75% | -0.99% |
Materials | XLB | 0.08% | 3.10% | 13.9% | 11.5% |
Real Estate | XLRE | -2.02% | -0.22% | 5.11% | -13.1% |
Technology | XLK | 4.15% | 6.61% | 13.6% | 6.35% |
Utilities | XLU | 0.23% | -2.60% | 0.80% | -21.1% |
Aerospace & Defense | XAR | 1.03% | -3.07% | -2.72% | -20.1% |
Biotech | XBI | -2.66% | 10.3% | 21.3% | 14.2% |
Homebuilder | XHB | 2.81% | 3.65% | 24.3% | 13.2% |
Retail | XRT | 2.72% | -0.24% | 11.9% | 8.36% |